Immage Biotherapeutics Corp Stock Debt To Equity
Immage Biotherapeutics Corp fundamentals help investors to digest information that contributes to Immage Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Immage Stock. The fundamental analysis module provides a way to measure Immage Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immage Biotherapeutics stock.
Immage |
Immage Biotherapeutics Corp Company Debt To Equity Analysis
Immage Biotherapeutics' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Immage Biotherapeutics Debt To Equity | 2.52 % |
Most of Immage Biotherapeutics' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immage Biotherapeutics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Immage Biotherapeutics Corp has a Debt To Equity of 2.518%. This is much higher than that of the sector and significantly higher than that of the Debt To Equity industry. The debt to equity for all United States stocks is notably lower than that of the firm.
Immage Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immage Biotherapeutics' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immage Biotherapeutics could also be used in its relative valuation, which is a method of valuing Immage Biotherapeutics by comparing valuation metrics of similar companies.Immage Biotherapeutics is currently under evaluation in debt to equity category among its peers.
Immage Fundamentals
| Return On Equity | -11.34 | |||
| Return On Asset | -4.96 | |||
| Current Valuation | 32.93 K | |||
| Shares Outstanding | 151.74 M | |||
| Shares Owned By Insiders | 69.85 % | |||
| Price To Earning | (0.01) X | |||
| EBITDA | (1.82 M) | |||
| Net Income | (216.48 K) | |||
| Cash And Equivalents | 53.69 K | |||
| Debt To Equity | 2.52 % | |||
| Current Ratio | 0.83 X | |||
| Cash Flow From Operations | (215.82 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 56.14 | |||
| Market Capitalization | 151 | |||
| Total Asset | 243.1 K | |||
| Working Capital | 17 K | |||
| Current Asset | 75 K | |||
| Current Liabilities | 58 K | |||
| Z Score | -24.62 | |||
| Net Asset | 243.1 K |
About Immage Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immage Biotherapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immage Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immage Biotherapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |